Anticoagulation therapy for stroke prevention in patients with nonvalvular atrial fibrillation
10.3760/cma.j.issn.1673-4165.2012.05.006
- VernacularTitle:非瓣膜性心房颤动患者卒中预防中的抗凝治疗
- Author:
Fei FENG
;
Yajun JIANG
- Publication Type:Journal Article
- Keywords:
Stroke;
Atrial Fibrillation;
Anticoagulants;
Thrombin;
Factor Xa
- From:
International Journal of Cerebrovascular Diseases
2012;20(5):347-350
- CountryChina
- Language:Chinese
-
Abstract:
Patients with nonvalvular atrial fibrillation are the high-risk population of ischemic stroke.Anticoagulation therapy is mainly used to prevent the occurrence of stroke in clinical practice.However,there are some difficulties in the conventional administration of oral anticoagulant warfarin because of some restrictions.There are a number of novel oral anticoagulants with promising data for the prevention of stroke in nonvalvular atrial fibrillation,such as direct thrombin inhibitor and coagulant factor X a inhibitor.
